Resources with keywords: packaging



VHF Clinical Specimen Packaging and Shipping
CDC

This guidance applies to Filoviruses, Arenaviruses, Rift Valley fever virus, Crimean Congo HFV. This guidance also applies to other high-consequence diseases that require a specialized laboratory, are highly pathogenic, and have no vaccine or treatment currently available, like Nipah virus disease.

Laboratory biosafety guidance related to SARS-CoV-2 (COVID-19): Interim guidance, 11 March 2024 (NEW 5/10, Website, Regulatory)
World Health Organization (WHO)
11 March 2024

Provides interim guidance on laboratory biosafety related to the SARS-CoV-2 virus to laboratories and stakeholders involved in COVID-19 laboratory work. This also includes the packaging and shipment requirements for sending specimens to WHO reference laboratories providing confirmatory and other testing for COVID-19.

SARS-CoV-2 Specimens: Packing and Shipping (NEW 6/23, Document, Regulatory)
CDC

Quick reference guide adapted from the CDC Laboratory Training course for shipping Covid samples.

Transport Media Safety Risk - Use Compatible Transport Media with SARS-CoV-2 Tests that Use Bleach - Letter to Clinical Laboratory Staff and Health Care Providers (Website, Regulatory)
FDA
1 June 2020

FDA issued a letter to clinical laboratory staff about a safety risk with using transport media and SARS-CoV-2 testing platforms that are not compatible.

SARS-CoV-2 Packaging and Shipping Information (Document)
ABSA: Emerging Infectious Diseases Committee (EIDC)
1 June 2020
Go to Top